CAM2029 reduces liver and cyst volume growth compared to placebo Well tolerated with no new or unexpected safety findings A follow-up Phase 3 study will be discussed with regulatory authorities PLD is ...

Liver cysts were found in over 80% of patients with ADPKD but were not associated with chronic kidney disease stage, Mayo classification, PKD1 or PKD2 genotype variant, liver enzyme levels, or quality ...

WASHINGTON -- Daily treatment with the novel drug saroglitazar significantly reduced liver fat in women with metabolic dysfunction-associated steatotic liver disease (MASLD) and polycystic ovary ...

Suchandrima Bhowmik has written over 300 articles on various health conditions, medical news, and recent breakthroughs. Her work appears in several publications, including Medical News Today, ...